Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02206971 · ClinicalTrials.gov registry record · NA

Biomarker Feedback for Smoking Cessation

A NA study, sponsored by Masonic Cancer Center, University of Minnesota.

Completed
Registry status
NA
Development phase
109
Enrollment target

NCT02206971: Completed NA study, sponsored by Masonic Cancer Center, University of Minnesota.

NCT02206971 is a NA study that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 109 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02206971, a NA study, has completed, sponsored by Masonic Cancer Center, University of Minnesota.

COMPLETED
Registry status
NA
Development phase
109 participants
Enrollment target

Study Summary

The purpose of this study is to examine the impact of providing light smokers with feedback about their health, including exposure to tobacco-related chemicals.

Primary Outcome

changes to biomarker levels with smoking reduction or cessation

Interventions

  • OTHER urine analyses feedback

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2012-05
Est. Completion 2014-12
Phase NA

What the finished NCT02206971 record still lists

NCT02206971 is an interventional study that assigns participants to a tested intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which urine analyses feedback is the first listed.

NCT02206971 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02206971 about?

NCT02206971 is a clinical study titled "Biomarker Feedback for Smoking Cessation". The purpose of this study is to examine the impact of providing light smokers with feedback about their health, including exposure to tobacco-related chemicals.

What is the current status of trial NCT02206971?

This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2012-05. Estimated completion is 2014-12.

What interventions are being tested in trial NCT02206971?

The interventions under investigation include: urine analyses feedback (OTHER).

Who is sponsoring clinical trial NCT02206971?

This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02206971's enrollment target sits among peer trials

109 825th of 2000 higher than 1,176 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02421380 · 109 participants · NA

    Characterization of Hyperpolarized Pyruvate MRI Reproducibility

  • NCT04526600 · 109 participants · NA

    Fidgeting and Attentional and Emotional Regulation in ADHD

  • NCT04835584 · 109 participants · Phase 1

    KRT-232 and TKI Study in Chronic Myeloid Leukemia

  • NCT06626516 · 109 participants · Phase 1

    Tebentafusp-tebn With LDT in Metastatic UM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02206971, the US trial registry maintained by the National Library of Medicine. NCT02206971 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.